StreetInsider.com News Articles

Form 8-K ZYNEX INC For: Dec 17

Thu, 18 Dec 2025 16:30:00 -0500

si-local-file:///var/storage/secattach/20251218/25759760.html

Form 8-K ZYNEX INC For: Dec 17

Thu, 18 Dec 2025 16:30:00 -0500

si-local-file:///var/storage/secattach/20251218/25759760.html

Form 8-K ZYNEX INC For: Dec 15

Tue, 16 Dec 2025 08:09:00 -0500

si-local-file:///var/storage/secattach/20251216/25744018.html

Form 8-K ZYNEX INC For: Dec 15

Tue, 16 Dec 2025 08:09:00 -0500

si-local-file:///var/storage/secattach/20251216/25744018.html

Zynex enters Chapter 11 restructuring with lender support

Tue, 16 Dec 2025 08:01:58 -0500

Zynex Inc. (NASDAQ: ZYXI) announced it has voluntarily entered Chapter 11 bankruptcy proceedings with financial support from its lenders. The medical technology company, which manufactures non-invasive devices for pain management and rehabilitation, said operations will continue without impact to patients, customers or employees.

Chief Executive Officer Steven Dyson stated the financing demonstrates lender confidence in the business and recent operational changes. The company said the restructuring aims to position Zynex for long-term stability.

Founded in 1996 and based in Englewood, Colorado, Zynex develops and sells medical devices used for pain management and rehabilitation. The company established a case website for stakeholders to

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Tue, 16 Dec 2025 08:00:00 -0500

ENGLEWOOD, Colo., Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation today announced it has voluntarily entered into a Chapter 11 court-supervised financial restructuring with the support of new financing from the Company's lenders.

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Tue, 16 Dec 2025 08:00:00 -0500

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Tue, 16 Dec 2025 08:00:00 -0500

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Tue, 16 Dec 2025 08:00:00 -0500

Form 3 ZYNEX INC For: Nov 11 Filed by: Aronzon Paul

Thu, 20 Nov 2025 20:58:00 -0500

si-local-file:///var/storage/secattach/20251120/25645906.html

Form 3 ZYNEX INC For: Nov 11 Filed by: Aronzon Paul

Thu, 20 Nov 2025 20:58:00 -0500

si-local-file:///var/storage/secattach/20251120/25645906.html

Form 10-Q ZYNEX INC For: Sep 30

Mon, 17 Nov 2025 17:22:00 -0500

si-local-file:///var/storage/secattach/20251117/25626268.html

Form 10-Q ZYNEX INC For: Sep 30

Mon, 17 Nov 2025 17:22:00 -0500

si-local-file:///var/storage/secattach/20251117/25626268.html

Form 8-K ZYNEX INC For: Nov 17

Mon, 17 Nov 2025 17:18:00 -0500

si-local-file:///var/storage/secattach/20251117/25626206.html

Form 8-K ZYNEX INC For: Nov 17

Mon, 17 Nov 2025 17:18:00 -0500

si-local-file:///var/storage/secattach/20251117/25626206.html

Zynex, Inc. (ZYXI) Misses Q3 EPS by $1.25, Misses on Revenue

Mon, 17 Nov 2025 17:16:43 -0500

Zynex, Inc. (NASDAQ: ZYXI) reported Q3 EPS of ($1.42), $1.25 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $13.36 million versus the consensus estimate of $22.71 million.

For earnings history and earnings-related data on Zynex, Inc. (ZYXI) click here.

Zynex Reports Third Quarter 2025 Financial Results